Semaglutide, more commonly known as Ozempic, can do more than help with weight loss.
A new clinical trial shows it helps treat poor blood flow in diabetic patients, which could otherwise lead to arm and leg amputations. Health reporter Katherine Ward has more on the Canadian connection.
Health
Ozempic can help prevent limb loss in some patients living with peripheral artery disease, trial shows
More Videos
-
1,800+ measles cases confirmed across Canada since Oct. 2024
-
Health Matters: Ontario health minister defends measles approach as case counts continue to rise
-
Is Canola oil good for you? Dietician dispels misconceptions around seed oils
-
Health Matters: Coconut meat recalled due to Salmonella
-
Microdosing Ozempic not recommended, doctors say
-
Health Matters: Long wait times for surgery, treatment costing Canadians
You are viewing an .
View Original Article